Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00322504 · ClinicalTrials.gov registry record · NA

Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study

A NA study of Breast Cancer, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT00322504: Completed NA study of Breast Cancer, sponsored by University of New Mexi.

NCT00322504 is a NA study of Breast Cancer that has completed, run by University of New Mexi. The registered enrollment target is 10 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00322504, a NA study of Breast Cancer, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

To assess the efficacy of acupuncture treatment in reducing symptoms of anxiety in women recently diagnosed with cancer. • To assess the efficacy of acupuncture treatment on improving perceived quality of life in women recently diagnosed with cancer.

Conditions Studied

Interventions

  • PROCEDURE Accupuncture

Study Locations (1)

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2006-01
Est. Completion 2006-09
Phase NA

Sponsor

University of New Mexi

76 total trials

What the Registry Record Tells You About NCT00322504

The ClinicalTrials.gov registry entry for NCT00322504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Accupuncture is the first listed.

NCT00322504 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT00322504 about?

NCT00322504 is a clinical study titled "Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study". To assess the efficacy of acupuncture treatment in reducing symptoms of anxiety in women recently diagnosed with cancer. • To assess the efficacy of acupuncture treatment on improving perceived quality of life in women recently diagnosed with cancer.

What is the current status of trial NCT00322504?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2006-01. Estimated completion is 2006-09.

What conditions does trial NCT00322504 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00322504?

The interventions under investigation include: Accupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT00322504?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00322504 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.